Jones Daphne E 4/A
4/A · AMN HEALTHCARE SERVICES INC · Filed Jul 9, 2026
Research Summary
AI-generated summary of this filing
AMN Healthcare Director Daphne Jones Exercises Derivatives; Receives RSUs
What Happened
- Daphne E. Jones, a director of AMN Healthcare Services, reported conversion/exercise of derivative securities and the vesting/settlement of RSUs on May 1, 2026.
- Records show 8,325 shares were recorded as converted/exercised (derivative M code) and 8,304 RSUs were recorded as newly acquired/awarded (A code). All transactions show $0 exercise/price — these were RSU vesting/conversions into common stock, not cash purchases or open‑market sales.
- After the corrected report, the reporting person beneficially owns 16,124 AMN shares.
Key Details
- Transaction date: May 1, 2026. Form 4 originally filed May 4, 2026 contained an error; this Form 4 was amended and filed July 9, 2026 to correct beneficial ownership (see below).
- Reported items: 8,325 shares from derivative exercise/conversion (M); 8,304 shares from RSU award/vesting (A). All entries show $0 per share (reflects RSU conversion/settlement).
- Shares owned after transaction: 16,124 (amended — prior filing overstated ownership by 1,000 shares).
- Holdings: Shares are held in the Daphne E. Jones Revocable Trust (reporting person is sole trustee and beneficiary).
- Footnotes of note: RSUs were granted under AMN equity plans (2017 and 2025 plans). Some RSUs vest based on a one‑year schedule or the company’s annual meeting; RSUs have no expiration and, per election, certain RSUs may settle at separation from service.
Context
- These transactions reflect RSU vesting/conversion (derivative settlement) rather than an open‑market buy or sale — commonly part of routine executive/director compensation.
- The filing is an amendment correcting a prior Form 4 (the May 4, 2026 filing overstated post‑transaction ownership by 1,000 shares). The amendment was filed July 9, 2026 to restate the correct ownership.
Insider Transaction Report
Form 4/AAmended
Jones Daphne E
Director
Transactions
- Exercise/Conversion
Common Stock
[F1][F2][F3]2026-05-01+8,325→ 16,124 total(indirect: By Trust) - Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]2026-05-01−8,325→ 0 total→ Common Stock (8,325 underlying) - Award
Restricted Stock Units
[F7][F8][F6]2026-05-01+8,304→ 8,304 total→ Common Stock (8,304 underlying)
Footnotes (8)
- [F1]AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
- [F2]Due to an administrative error, the Form 4 filed by the reporting person on May 4, 2026 overstated the amount of securities beneficially owned following the reported transaction by 1,000 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 16,124 securities were beneficially owned by reporting person, not 17,124 as previously reported.
- [F3]These shares are held in the Daphne E. Jones Revocable Trust, of which the Reporting Person is the sole trustee and the sole beneficiary.
- [F4]The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
- [F5]The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.
- [F6]RSUs do not have an expiration date.
- [F7]The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
- [F8]The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.
Signature
/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Daphne E. Jones|2026-07-09